Match tier
Confirmed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
H
Héctor Rosas-Hernández
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Staff Fellow
Also affiliated: United States Food and Drug Administration (2014–2019); Mexican Social Security Institute (2023); Autonomous University of San Luis Potosí (2009–2017); Hospital Angeles Pedregal (2023); Montagu Hospital (2023); Hospital Central Militar (2012–2016); Institute for Social Security and Services for State Workers (2023)
Staff Researcher
20 h-index
64 pubs
1,027 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Héctor Rosas-Hernández's research focuses on understanding the mechanisms of neurovascular dysfunction and the impact of environmental factors on the central nervous system. He has investigated the potential for SARS-CoV-2 to infect the central nervous system through the olfactory bulb or the blood-brain barrier. His work also includes studying the neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats, examining how such exposures can alter brain function and chemistry.
Further contributing to the field of neurological research, Rosas-Hernández has been involved in modeling neurovascular dysfunction in Alzheimer's disease using an isogenic brain-chip model. This approach allows for the study of complex disease processes in a controlled laboratory setting. He leads a research group and has published 64 papers, accumulating over 1,020 citations, with an h-index of 20. His key collaborators include Katelin S. Matazel, W. Drew Gill, John Talpos, and Susan M. Burks, all from the National Center for Toxicological Research, with whom he has co-authored multiple publications.
Metrics
- h-index: 20
- Publications: 64
- Citations: 1,027
Selected Publications
-
Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model (2026)
-
Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model (2026)
-
Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model (2026)
-
Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model (2026)
-
Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model (2026)
-
Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats (2021)
-
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? (2021)
-
Modification of methods to use Congo-red stain to simultaneously visualize amyloid plaques and tangles in human and rodent brain tissue sections (2020)
-
Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer’s Disease (2020)
-
Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research (2019)
-
P4‐064: EVALUATION OF TAU NEUROPATHOLOGY AND OTHER KEY PROTEINS IN THE OLFACTORY BULB AND ITS CORRELATION WITH HIPPOCAMPUS IN HUMAN ALZHEIMER'S DISEASE (2019)
-
Stretch-Induced Deformation as a Model to Study Dopaminergic Dysfunction in Traumatic Brain Injury (2019)
-
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro (2019)
-
Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer’s Disease (2019)
-
Cytotoxicity profile of pristine graphene on brain microvascular endothelial cells (2019)
Collaboration Network
Top Collaborators
Katelin S. Matazel
National Center for Toxicological Research
4 shared publications
In database
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
W. Drew Gill
National Center for Toxicological Research
4 shared publications
In database
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Lorna Ewart
Emulate (United States) (US)
4 shared publications
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Randy S. Daughters
Emulate (United States) (US)
4 shared publications
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Andrew Shen
National Center for Toxicological Research
3 shared publications
In database
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Additional file 1 of Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Andrew N. Shen
National Center for Toxicological Research
2 shared publications
In database
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
- Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Susan M. Burks
National Center for Toxicological Research
1 shared publication
In database
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Manuel Alejandro Ramirez-Lee
National Center for Toxicological Research
1 shared publication
In database
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Elvis Cuevas
National Center for Toxicological Research (US)
1 shared publication
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
John Talpos
National Center for Toxicological Research
1 shared publication
In database
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Timothy J. Flanigan
National Center for Toxicological Research
1 shared publication
In database
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
Sherry A. Ferguson
National Center for Toxicological Research (US)
1 shared publication
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
Charles Law
National Center for Toxicological Research (US)
1 shared publication
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
Elvis Y Cuevas-Martı́nez
National Center for Toxicological Research
1 shared publication
In database
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
Suzanne Fitzpatrick
Center for Food Safety and Applied Nutrition (US)
1 shared publication
- Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats
Similar Researchers
Based on overlapping research topics
Timothy J. Flanigan
National Center for Toxicological Research
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
W. Drew Gill
National Center for Toxicological Research
Neuroscience and Neuropharmacology Research
Disease Models, Animal
Alzheimer's disease research and treatments
Susan M. Lantz
National Center for Toxicological Research
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Sumit Sarkar
National Center for Toxicological Research
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Elizabeth A Duplechain
Arkansas State University
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Heidi D. Hughes-Meredith
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal